Literature DB >> 25243513

The histology of kidney transplant failure: a long-term follow-up study.

Maarten Naesens1, Dirk R J Kuypers, Katrien De Vusser, Pieter Evenepoel, Kathleen Claes, Bert Bammens, Björn Meijers, Ben Sprangers, Jacques Pirenne, Diethard Monbaliu, Ina Jochmans, Evelyne Lerut.   

Abstract

BACKGROUND: The relative impact on renal allograft outcome of specific histological diagnoses versus nonspecific chronic histological damage remains unclear.
METHODS: All 1,197 renal allograft recipients who were transplanted at a single center between 1991 and 2001 were included. All posttransplant renal allograft indication biopsies performed in this cohort during follow-up (mean, 14.5±2.80 years after transplantation) were rescored according to the current histological criteria and associated with death-censored graft outcome.
RESULTS: In this cohort, 1,365 allograft indication biopsies were performed. Specific diagnoses were present in 69.4% of graft biopsies before graft loss, but 30.6% of grafts did not have specific diagnoses in the last biopsy before graft loss. Only 14.6% of the patients did never have any specific disease diagnosed before graft loss. Extensive interstitial fibrosis and tubular atrophy without a clear cause was identified as the single cause of graft loss in only 6.9% of the cases. Acute T-cell-mediated rejection and changes suggestive of acute antibody-mediated rejection, diagnosed after the first year posttransplant, associated independently with graft survival. Transplant glomerulopathy increased over time after transplantation and represented a major risk for graft loss, as well as de novo or recurrent glomerular pathologies and polyomavirus nephropathy. Chronic histological injury associated with graft outcome, independent of specific diagnoses.
CONCLUSION: Renal allograft loss is multifactorial. Chronic histological damage and specific diseases had additive and independent impact on graft outcome. Chronic damage should be taken into account in prognostication of renal allograft outcome and could be implemented in treatment algorithms for specific diseases of kidney allografts.

Entities:  

Mesh:

Year:  2014        PMID: 25243513     DOI: 10.1097/TP.0000000000000183

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  50 in total

1.  Novel markers of graft outcome in a cohort of kidney transplanted patients: a cohort observational study.

Authors:  C Alfieri; A Regalia; G Moroni; D Cresseri; F Zanoni; M Ikehata; P Simonini; M P Rastaldi; G Tripepi; C Zoccali; C Chatziantoniou; Piergiorgio Messa
Journal:  J Nephrol       Date:  2019-01-10       Impact factor: 3.902

2.  Transcriptional Changes in Kidney Allografts with Histology of Antibody-Mediated Rejection without Anti-HLA Donor-Specific Antibodies.

Authors:  Jasper Callemeyn; Evelyne Lerut; Henriette de Loor; Ingrid Arijs; Olivier Thaunat; Alice Koenig; Vannary Meas-Yedid; Jean-Christophe Olivo-Marin; Philip Halloran; Jessica Chang; Lieven Thorrez; Dirk Kuypers; Ben Sprangers; Leentje Van Lommel; Frans Schuit; Marie Essig; Wilfried Gwinner; Dany Anglicheau; Pierre Marquet; Maarten Naesens
Journal:  J Am Soc Nephrol       Date:  2020-07-08       Impact factor: 10.121

3.  Infectious complications as the leading cause of death after kidney transplantation: analysis of more than 10,000 transplants from a single center.

Authors:  Flávio de Castro Rodrigues Ferreira; Marina Pontello Cristelli; Mayara Ivani Paula; Henrique Proença; Claudia Rosso Felipe; Helio Tedesco-Silva; José Osmar Medina-Pestana
Journal:  J Nephrol       Date:  2017-02-17       Impact factor: 3.902

4.  Urine biomarkers in renal allograft.

Authors:  Hongting Wang; Zuan-Tao Lin; Yulin Yuan; Tianfu Wu
Journal:  J Transl Int Med       Date:  2016-09-23

5.  Assessing rejection-related disease in kidney transplant biopsies based on archetypal analysis of molecular phenotypes.

Authors:  Jeff Reeve; Georg A Böhmig; Farsad Eskandary; Gunilla Einecke; Carmen Lefaucheur; Alexandre Loupy; Philip F Halloran
Journal:  JCI Insight       Date:  2017-06-15

6.  Genome-wide non-HLA donor-recipient genetic differences influence renal allograft survival via early allograft fibrosis.

Authors:  Zhongyang Zhang; Madhav C Menon; Weijia Zhang; Eli Stahl; Bao-Li Loza; Ivy A Rosales; Zhengzi Yi; Khadija Banu; Felipe Garzon; Zeguo Sun; Chengguo Wei; Weiqing Huang; Qisheng Lin; Ajay Israni; Brendan J Keating; Robert B Colvin; Ke Hao; Barbara Murphy
Journal:  Kidney Int       Date:  2020-05-23       Impact factor: 10.612

Review 7.  Kidney Fibrosis: Origins and Interventions.

Authors:  Thomas Vanhove; Roel Goldschmeding; Dirk Kuypers
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

8.  Proteinuria as a Noninvasive Marker for Renal Allograft Histology and Failure: An Observational Cohort Study.

Authors:  Maarten Naesens; Evelyne Lerut; Marie-Paule Emonds; Albert Herelixka; Pieter Evenepoel; Kathleen Claes; Bert Bammens; Ben Sprangers; Björn Meijers; Ina Jochmans; Diethard Monbaliu; Jacques Pirenne; Dirk R J Kuypers
Journal:  J Am Soc Nephrol       Date:  2015-07-07       Impact factor: 10.121

9.  Magnetic Resonance Elastography to Assess Fibrosis in Kidney Allografts.

Authors:  Anish Kirpalani; Eyesha Hashim; General Leung; Jin K Kim; Adriana Krizova; Serge Jothy; Maya Deeb; Nan N Jiang; Lauren Glick; Gevork Mnatzakanian; Darren A Yuen
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-30       Impact factor: 8.237

Review 10.  Kidney allograft fibrosis: what we learned from latest translational research studies.

Authors:  Simona Granata; Claudia Benedetti; Giovanni Gambaro; Gianluigi Zaza
Journal:  J Nephrol       Date:  2020-03-19       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.